Literature DB >> 28987789

Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.

Antonio La Marca1, Maria Giulia Minasi2, Giovanna Sighinolfi3, Pierfrancesco Greco2, Cindy Argento4, Valentina Grisendi4, Francesco Fiorentino5, Ermanno Greco2.   

Abstract

OBJECTIVE: To study the relative role of female age and ovarian reserve, measured through serum antimüllerian hormone (AMH) in determining the rate and number of euploid blastocysts in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles.
DESIGN: Retrospective analysis of cycles performed in 2014-2015.
SETTING: Tertiary referral IVF center. PATIENT(S): A total of 578 infertile couples undergoing IVF/ICSI and preimplantation genetic screening (PGS) analysis. INTERVENTIONS(S): All embryos were cultured and biopsied at the blastocyst stage. The method involved whole-genome amplification followed by array comparative genome hybridization. Serum AMH was measured by means of the modified Beckman Coulter AMH Gen II assay. MAIN OUTCOME MEASURES: The rate and number of euploid blastocysts and their correlation with ovarian reserve and response to stimulation. RESULT(S): The mean (±SD) age of patients was 37.6 ± 4.1 years, and the mean number of blastocysts per patient was 3.1 ± 2. The total number of blastocysts available to the analysis was 1,814, and 36% of them were euploid after PGS. Age and serum AMH were significantly and independently related to the rate of euploid blastocysts available for patients. As an effect of the cohort size, the number of mature oocytes positively affected the total number of euploid blastocysts per patient. CONCLUSION(S): A strong positive age-independent relationship between AMH level and the rate of euploid blastocysts was found. This confirms that the measurement of ovarian reserve by means of AMH has high relevance when counseling infertile patients.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMH; IVF/ICSI; euploid blastocyst; female age; mature oocytes

Mesh:

Substances:

Year:  2017        PMID: 28987789     DOI: 10.1016/j.fertnstert.2017.08.029

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  22 in total

1.  Micro-RNAs involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve.

Authors:  Irene Woo; Lane K Christenson; Sumedha Gunewardena; Sue Ann Ingles; Semara Thomas; Ali Ahmady; Karine Chung; Kristin Bendikson; Richard Paulson; Lynda K McGinnis
Journal:  J Assist Reprod Genet       Date:  2018-07-09       Impact factor: 3.412

2.  The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool.

Authors:  Randi H Goldman; Catherine Racowsky; Leslie V Farland; Janis H Fox; Santiago Munné; Lia Ribustello; Elizabeth S Ginsburg
Journal:  J Assist Reprod Genet       Date:  2018-07-31       Impact factor: 3.412

3.  Logistic regression analyses of factors affecting the euploidy of blastocysts undergoing in vitro fertilization and preimplantation genetic testing.

Authors:  Zhiping Zhang; Lei Zhang; Yaoqin Wang; Xingyu Bi; Lixia Liang; Yuan Yuan; Dan Su; Xueqing Wu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients.

Authors:  Xingping Zhao; Yunzhi Liu; Aiqian Zhang; Bingsi Gao; Qing Feng; Huan Huang; Xiuting Zhu; Xin Sun; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

5.  Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus.

Authors:  Giovanni Coticchio; Barry Behr; Alison Campbell; Marcos Meseguer; Dean E Morbeck; Valerio Pisaturo; Carlos E Plancha; Denny Sakkas; Yanwen Xu; Thomas D'Hooghe; Evelyn Cottell; Kersti Lundin
Journal:  J Assist Reprod Genet       Date:  2021-02-18       Impact factor: 3.412

6.  Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.

Authors:  Amanda Skillern; Whitney Leonard; Jordyn Pike; Winifred Mak
Journal:  J Assist Reprod Genet       Date:  2021-02-03       Impact factor: 3.412

Review 7.  Untapped Reserves: Controlling Primordial Follicle Growth Activation.

Authors:  Amanda Kallen; Alex J Polotsky; Joshua Johnson
Journal:  Trends Mol Med       Date:  2018-02-13       Impact factor: 11.951

8.  Live birth rate from euploid blastocysts is not associated with infertility etiology or oocyte source following frozen-thawed embryo transfer (FET): analysis of 4148 cycles reported to SART CORS.

Authors:  F Meng; M Goldsammler; E Wantman; E Buyuk; S K Jindal
Journal:  J Assist Reprod Genet       Date:  2020-11-06       Impact factor: 3.412

Review 9.  Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

Authors:  Sarah F Lensen; Jack Wilkinson; Jori A Leijdekkers; Antonio La Marca; Ben Willem J Mol; Jane Marjoribanks; Helen Torrance; Frank J Broekmans
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

10.  Degree of mosaicism in trophectoderm does not predict pregnancy potential: a corrected analysis of pregnancy outcomes following transfer of mosaic embryos.

Authors:  Vitaly A Kushnir; Sarah K Darmon; David H Barad; Norbert Gleicher
Journal:  Reprod Biol Endocrinol       Date:  2018-01-26       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.